强直性脊柱炎中炎症小体激活与肠道菌群失调相关
该研究评估了强直性脊柱炎(AS)患者和啮齿类动物模型中炎症小体通路的激活及其与菌群失调的关系。结果显示,AS患者回肠中NLRP3、NLRC4、AIM2、CASP1、IL1B和IL18表达增加,且与黏附侵袭性细菌评分相关;NLRP3表达与疾病活动度相关。炎症小体激活通过IL-1β依赖机制驱动III型细胞因子产生。
要点
- AS患者回肠炎症小体成分表达显著增加,且caspase-1活性升高。
- NLRP3表达与ASDAS-CRP和IL23A表达相关。
- 炎症小体激活通过IL-1β依赖机制诱导IL23A、IL17A和IL22。
核心结论
- 炎症小体激活在AS啮齿类模型和患者中发生,与菌群失调相关,并参与触发SKG小鼠回肠炎。
- 在AS患者中,炎症小体通过IL-1β依赖机制驱动III型细胞因子产生。
研究设计与样本
- 研究评估了40例AS患者、20例健康对照和10例克罗恩病患者的肠道和外周血炎症小体通路,使用qRT-PCR、免疫组化、流式细胞术和共聚焦显微镜。
- 在HLA-B27转基因大鼠中给予抗生素,在SKG小鼠中给予NLRP3抑制剂MCC950,评估回肠和关节组织。
主要发现
- HLA-B27转基因大鼠肠道中Nlrp3、Nlrc4和Aim2表达增加,抗生素治疗降低其表达(P < 0.05)。
- 在curdlan处理的SKG小鼠中,NLRP3阻断预防回肠炎并延迟关节炎发作(P < 0.05)。
- 与健康对照相比,AS患者回肠中NLRP3(倍数诱导2.33 vs 22.2;P < 0.001)、NLRC4(1.90 vs 6.47;P < 0.001)、AIM2(2.40 vs 20.8;P < 0.001)、CASP1(2.53 vs 24.8;P < 0.001)、IL1B(1.07 vs 10.93;P < 0.001)和IL18(2.56 vs 15.67;P < 0.001)过表达,caspase 1活性增加(P < 0.01)。
- AS患者黏附侵袭性黏膜相关细菌评分更高(P < 0.01),且与外周血单核细胞中炎症小体成分表达相关(P < 0.001)。
- NLRP3表达与疾病活动度(ASDAS-CRP)(r2 = 0.28,P < 0.01)和IL23A表达(r2 = 0.34,P < 0.001)相关。
关键数值与推荐
- AS患者回肠NLRP3倍数诱导2.33 vs 22.2(P < 0.001),NLRC4 1.90 vs 6.47(P < 0.001),AIM2 2.40 vs 20.8(P < 0.001),CASP1 2.53 vs 24.8(P < 0.001),IL1B 1.07 vs 10.93(P < 0.001),IL18 2.56 vs 15.67(P < 0.001)。
- NLRP3表达与ASDAS-CRP相关(r2 = 0.28,P < 0.01),与IL23A表达相关(r2 = 0.34,P < 0.001)。
临床怎么用
- AS患者存在炎症小体通路激活,与肠道菌群失调和疾病活动度相关。
- 靶向炎症小体或IL-1β可能成为AS的潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We undertook this study to evaluate the activation and functional relevance of inflammasome pathways in ankylosing spondylitis (AS) patients and rodent models and their relationship to dysbiosis. METHODS: An inflammasome pathway was evaluated in the gut and peripheral blood from 40 AS patients using quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR), immunohistochemistry (IHC), flow cytometry, and confocal microscopy, and was compared to that of 20 healthy controls and 10 patients with Crohn's disease. Bacteria was visualized using silver stain in human samples, and antibiotics were administered to HLA-B27-transgenic rats. The NLRP3 inhibitor MCC950 was administered to SKG mice, and ileal and joint tissues were assessed by IHC analysis and real-time qRT-PCR. The role of inflammasome in modulating the interleukin-23 (IL-23)/IL-17 axis was studied ex vivo. RESULTS: Expression levels of Nlrp3, Nlrc4, and Aim2 were increased in the gut of HLA-B27-transgenic rats and reduced by antibiotic treatment (P < 0.05). In curdlan-treated SKG mice, NLRP3 blockade prevented ileitis and delayed arthritis onset (P < 0.05). Compared to healthy controls, AS patients demonstrated overexpression of NLRP3 (fold induction 2.33 versus 22.2; P < 0.001), NLRC4 (fold induction 1.90 versus 6.47; P < 0.001), AIM2 (fold induction 2.40 versus 20.8; P < 0.001), CASP1 (fold induction 2.53 versus 24.8; P < 0.001), IL1B (fold induction 1.07 versus 10.93; P < 0.001), and IL18 (fold induction 2.56 versus 15.67; P < 0.001) in the ileum, and caspase 1 activity was increased (P < 0.01). The score of adherent and invasive mucosa-associated bacteria was higher in AS (P < 0.01) and correlated with the expression of inflammasome components in peripheral blood mononuclear cells (P < 0.001). NLRP3 expression was associated with disease activity (the Ankylosing Spondylitis Disease Activity Score using the C-reactive protein level) (r2 = 0.28, P < 0.01) and with IL23A expression (r2 = 0.34, P < 0.001). In vitro, inflammasome activation in AS monocytes was paralleled by increased serum levels of IL-1β and IL-18. Induction of IL23A, IL17A, and IL22 was IL-1β-dependent. CONCLUSION: Inflammasome activation occurs in rodent models of AS and in AS patients, is associated with dysbiosis, and is involved in triggering ileitis in SKG mice. Inflammasomes drive type III cytokine production with an IL-1β-dependent mechanism in AS patients.
引用
- Guggino G, Mauro D, Rizzo A, et al. Inflammasome Activation in Ankylosing Spondylitis Is Associated With Gut Dysbiosis. Arthritis Rheumatol. 2021. PMID: 33452867. doi:10.1002/art.41644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。